schizophrenia program (Pasithea Therapeutics/Evotec)

N/A

Report date: 2025/01/26 16:20:09
NME

Base Information

Drug Nameschizophrenia program (Pasithea Therapeutics/Evotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPasithea Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesPasithea Therapeutics CorpEvotec SE
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A